Abbott Laboratories (ABT)vsRapid Micro Biosystems Inc (RPID)
ABT
Abbott Laboratories
$104.83
+0.74%
HEALTHCARE · Cap: $180.82B
RPID
Rapid Micro Biosystems Inc
$2.43
+1.25%
HEALTHCARE · Cap: $104.56M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 131880% more annual revenue ($44.33B vs $33.59M). ABT leads profitability with a 14.7% profit margin vs -140.3%. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
RPID
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-315.5%
Fair Value
$25.23
Current Price
$104.83
$79.60 premium
Intrinsic value data unavailable for RPID.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Revenue surging 37.3% year-over-year
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -86.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : RPID
The strongest argument for RPID centers on Revenue Growth. Revenue growth of 37.3% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : RPID
The primary concerns for RPID are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
ABT profiles as a value stock while RPID is a hypergrowth play — different risk/reward profiles.
RPID carries more volatility with a beta of 1.39 — expect wider price swings.
RPID is growing revenue faster at 37.3% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 33/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Rapid Micro Biosystems Inc
HEALTHCARE · MEDICAL DEVICES · USA
Rapid Micro Biosystems Inc is an innovative biotechnology company focused on revolutionizing microbiological quality control for the pharmaceutical and biotechnology industries. Utilizing advanced automated growth-based microbial detection technologies, the firm significantly improves the precision and efficiency of microbial testing, ensuring high product quality and regulatory compliance. With an increasing demand for rapid, reliable quality control solutions in regulated environments, Rapid Micro is well-positioned to meet these urgent market needs and lead the evolution of microbiological testing methodologies.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?